Ceftaroline fosamil doses and breakpoints for Staphylococcus aureus in complicated skin and soft tissue infections

OBJECTIVES: To describe the pharmacokinetic/pharmacodynamic (PK/PD) modelling and microbiological data that were used to support the recent European approval of ceftaroline fosamil 600 mg q8h by 2 h intravenous (iv) infusion for patients with complicated skin and soft tissue infections (cSSTIs) caus...

Descripción completa

Detalles Bibliográficos
Autores principales: Das, Shampa, Li, Jianguo, Iaconis, Joseph, Zhou, Diansong, Stone, Gregory G, Yan, Jean Li, Melnick, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6337900/
https://www.ncbi.nlm.nih.gov/pubmed/30380060
http://dx.doi.org/10.1093/jac/dky439

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6337900/
https://www.ncbi.nlm.nih.gov/pubmed/30380060
http://dx.doi.org/10.1093/jac/dky439

Ejemplares similares